We are analyzing https://link.springer.com/article/10.1007/s11481-006-9018-2.

Title:
Neurobiology of Multiple Insults: HIV-1-Associated Brain Disorders in Those Who Use Illicit Drugs | Journal of Neuroimmune Pharmacology
Description:
Despite two decades of research, certain aspects of HIV-related central nervous system (CNS) disease remain poorly understood. HIV targets microglia and macrophages within the CNS and enters the brain compartment early. However, HIV is there held in check apparently until the onset of significant immune compromise, when viral replication, microglial activation, neuronal damage, and cognitive impairment are likely to ensue. Illicit drug abuse continues to be a significant risk factor for HIV transmission worldwide. Whether HIV-related CNS disease is more prevalent or more severe in this risk group has long been debated. Drugs of abuse can of themselves cause immune suppression, blood–brain barrier breakdown, microglial activation, and neuronal injury. This review presents evidence that HIV associated CNS disorders are indeed accentuated in drug abusers. However, the advent of effective therapy has added a new dimension, which must be taken into consideration. Treated individuals are surviving much longer and HIV encephalitis and HIV-associated dementia have become much less common. However, more subtle forms of CNS damage are emerging. Examination of the brains of individuals who have been treated long term with highly active antiretroviral therapy (HAART) reveals a surprising degree of microglial activation, comparable at times to that seen formerly in milder cases of HIV encephalitis. In addition, these individuals show evidence of increased deposition of neurodegenerative proteins, particularly hyperphosphorylated tau. Similar observations have been made in young opiate abusers who are HIV negative. Taken together, these results suggest that neuroinflammation and neurodegeneration, which are clinically silent at present, may cause problems in the future in HAART-treated subjects.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

google, scholar, pubmed, cas, article, hiv, aids, brain, infection, bell, drug, dementia, pathol, therapy, neuropathol, human, abuse, antiretroviral, immunodeficiency, virus, hivassociated, system, neurol, neuropathology, nervous, cocaine, central, brains, haart, era, complex, research, anthony, cns, immune, study, acta, simmonds, patients, brew, mcarthur, neurovirol, privacy, cookies, content, journal, drugs, review, disease, viral,

Topics {✒️}

month download article/chapter immune-competent mononuclear phagocytes antibody-positive virus carrier juan-carlos arango & iain hiv-seropositive homosexual men asymptomatic hiv-positive patients hiv-infected drug addicts blood–brain barrier breakdown acquired immunodeficiency syndrome pre-symptomatic hiv infection human immunodeficiency virus human immunodeficiency virus full article pdf hepatic encephalopathy hiv-related cns disease privacy choices/manage cookies central nervous system metabolic encephalopathy perpetrated sharer lr significant immune compromise neuroimmune pharmacology aims hiv-related studies human brain tissue anti-retroviral therapy endogenous opioid system csf amyloid beta42 review presents evidence anthony ic pre-aids subjects haart-treated subjects significant risk factor hiv-1 infections early hiv-1 infection magnetic resonance study electron microscopical study comparative international study torres-munoz serotonin transporter gene multinucleated giant cells hippocampal neurons isolated laser capture microdissection alexander donald building western general hospital blood–brain barrier article journal young drug abusers conditions privacy policy injection drug users hiv cellular reservoirs hiv-1 gene sequences

Questions {❓}

Cocaine's connection to AIDS dementia and vasculitis?
Tyor W, Middaugh LD (1999) Do alcohol and cocaine abuse alter the course of the HIV-associated dementia complex?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Neurobiology of Multiple Insults: HIV-1-Associated Brain Disorders in Those Who Use Illicit Drugs
         description:Despite two decades of research, certain aspects of HIV-related central nervous system (CNS) disease remain poorly understood. HIV targets microglia and macrophages within the CNS and enters the brain compartment early. However, HIV is there held in check apparently until the onset of significant immune compromise, when viral replication, microglial activation, neuronal damage, and cognitive impairment are likely to ensue. Illicit drug abuse continues to be a significant risk factor for HIV transmission worldwide. Whether HIV-related CNS disease is more prevalent or more severe in this risk group has long been debated. Drugs of abuse can of themselves cause immune suppression, blood–brain barrier breakdown, microglial activation, and neuronal injury. This review presents evidence that HIV associated CNS disorders are indeed accentuated in drug abusers. However, the advent of effective therapy has added a new dimension, which must be taken into consideration. Treated individuals are surviving much longer and HIV encephalitis and HIV-associated dementia have become much less common. However, more subtle forms of CNS damage are emerging. Examination of the brains of individuals who have been treated long term with highly active antiretroviral therapy (HAART) reveals a surprising degree of microglial activation, comparable at times to that seen formerly in milder cases of HIV encephalitis. In addition, these individuals show evidence of increased deposition of neurodegenerative proteins, particularly hyperphosphorylated tau. Similar observations have been made in young opiate abusers who are HIV negative. Taken together, these results suggest that neuroinflammation and neurodegeneration, which are clinically silent at present, may cause problems in the future in HAART-treated subjects.
         datePublished:2006-05-05T00:00:00Z
         dateModified:2006-05-05T00:00:00Z
         pageStart:182
         pageEnd:191
         sameAs:https://doi.org/10.1007/s11481-006-9018-2
         keywords:
            review
            HIV/AIDS
            drug abuse
            dementia
            neuropathology
            HAART
            Neurosciences
            Immunology
            Pharmacology/Toxicology
            Virology
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig5_HTML.gif
         isPartOf:
            name:Journal of Neuroimmune Pharmacology
            issn:
               1557-1904
               1557-1890
            volumeNumber:1
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jeanne E. Bell
               affiliation:
                     name:University of Edinburgh
                     address:
                        name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
                        type:PostalAddress
                     type:Organization
                     name:Western General Hospital
                     address:
                        name:Pathology (Neuropathology), Alexander Donald Building, Western General Hospital, Edinburgh, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Juan-Carlos Arango
               affiliation:
                     name:University of Edinburgh
                     address:
                        name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Iain C. Anthony
               affiliation:
                     name:University of Edinburgh
                     address:
                        name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neurobiology of Multiple Insults: HIV-1-Associated Brain Disorders in Those Who Use Illicit Drugs
      description:Despite two decades of research, certain aspects of HIV-related central nervous system (CNS) disease remain poorly understood. HIV targets microglia and macrophages within the CNS and enters the brain compartment early. However, HIV is there held in check apparently until the onset of significant immune compromise, when viral replication, microglial activation, neuronal damage, and cognitive impairment are likely to ensue. Illicit drug abuse continues to be a significant risk factor for HIV transmission worldwide. Whether HIV-related CNS disease is more prevalent or more severe in this risk group has long been debated. Drugs of abuse can of themselves cause immune suppression, blood–brain barrier breakdown, microglial activation, and neuronal injury. This review presents evidence that HIV associated CNS disorders are indeed accentuated in drug abusers. However, the advent of effective therapy has added a new dimension, which must be taken into consideration. Treated individuals are surviving much longer and HIV encephalitis and HIV-associated dementia have become much less common. However, more subtle forms of CNS damage are emerging. Examination of the brains of individuals who have been treated long term with highly active antiretroviral therapy (HAART) reveals a surprising degree of microglial activation, comparable at times to that seen formerly in milder cases of HIV encephalitis. In addition, these individuals show evidence of increased deposition of neurodegenerative proteins, particularly hyperphosphorylated tau. Similar observations have been made in young opiate abusers who are HIV negative. Taken together, these results suggest that neuroinflammation and neurodegeneration, which are clinically silent at present, may cause problems in the future in HAART-treated subjects.
      datePublished:2006-05-05T00:00:00Z
      dateModified:2006-05-05T00:00:00Z
      pageStart:182
      pageEnd:191
      sameAs:https://doi.org/10.1007/s11481-006-9018-2
      keywords:
         review
         HIV/AIDS
         drug abuse
         dementia
         neuropathology
         HAART
         Neurosciences
         Immunology
         Pharmacology/Toxicology
         Virology
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11481-006-9018-2/MediaObjects/11481_2006_9018_Fig5_HTML.gif
      isPartOf:
         name:Journal of Neuroimmune Pharmacology
         issn:
            1557-1904
            1557-1890
         volumeNumber:1
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jeanne E. Bell
            affiliation:
                  name:University of Edinburgh
                  address:
                     name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
                     type:PostalAddress
                  type:Organization
                  name:Western General Hospital
                  address:
                     name:Pathology (Neuropathology), Alexander Donald Building, Western General Hospital, Edinburgh, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Juan-Carlos Arango
            affiliation:
                  name:University of Edinburgh
                  address:
                     name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Iain C. Anthony
            affiliation:
                  name:University of Edinburgh
                  address:
                     name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neuroimmune Pharmacology
      issn:
         1557-1904
         1557-1890
      volumeNumber:1
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Edinburgh
      address:
         name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
         type:PostalAddress
      name:Western General Hospital
      address:
         name:Pathology (Neuropathology), Alexander Donald Building, Western General Hospital, Edinburgh, UK
         type:PostalAddress
      name:University of Edinburgh
      address:
         name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
         type:PostalAddress
      name:University of Edinburgh
      address:
         name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jeanne E. Bell
      affiliation:
            name:University of Edinburgh
            address:
               name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
               type:PostalAddress
            type:Organization
            name:Western General Hospital
            address:
               name:Pathology (Neuropathology), Alexander Donald Building, Western General Hospital, Edinburgh, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Juan-Carlos Arango
      affiliation:
            name:University of Edinburgh
            address:
               name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
               type:PostalAddress
            type:Organization
      name:Iain C. Anthony
      affiliation:
            name:University of Edinburgh
            address:
               name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
      name:Pathology (Neuropathology), Alexander Donald Building, Western General Hospital, Edinburgh, UK
      name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
      name:Neuropathology Division & Forensic Medicine Unit, University of Edinburgh, Scotland, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(211)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.38s.

LINK . SPRINGER . COM {}